Company

SynCardia Systems, Inc.

SynCardia Systems develops the Total Artificial Heart for patients with severe heart failure.

About

Founded in 2001 and based in Tucson, US, SynCardia Systems develops the SynCardia Total Artificial Heart, a temporary heart replacement for patients with end-stage biventricular heart failure awaiting transplant. The device has been implanted over 2,000 times in more than 20 countries. The company raised USD 6.41 mn in 2023 and has completed 11 deals. Don Webber and Patrick Schnegelsberg are listed in its CEO team.

5Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in